• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有完全成熟免疫表型的小儿T淋巴细胞白血病:快速且具有挑战性的诊断

Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging Diagnosis.

作者信息

Cheng Jinjun, Wang Yannan, Gong Shunyou, Wistinghausen Birte, Jacobs Shana, Schore Reuven J, Toner Keri

机构信息

Department of Pathology and Laboratory Medicine.

Centers for Cancer and Blood Disorders and Cancer and Immunology Research, Children's National Hospital.

出版信息

J Pediatr Hematol Oncol. 2025 Jan 1;47(1):e58-e61. doi: 10.1097/MPH.0000000000002967. Epub 2024 Dec 31.

DOI:10.1097/MPH.0000000000002967
PMID:39737635
Abstract

Children with T-ALL/LBL require prompt diagnosis and treatment. Flow cytometric analysis of T-lineage and immaturity markers usually leads to a straightforward diagnosis. However, rare cases of T-ALL expressing bright CD45 and lacking expression of immature markers can be a diagnostic conundrum and difficult to differentiate from mature T-cell lymphomas lacking surface CD3 expression or aberrantly expressing immature markers, which affects treatment decisions and prognosis. Here, we summarize the clinical, pathologic, and genetic features of 3 pediatric T-ALL cases with an entirely mature immunophenotype.

摘要

患有T-ALL/LBL的儿童需要及时诊断和治疗。对T系和不成熟标志物进行流式细胞术分析通常可得出明确诊断。然而,罕见的T-ALL病例表现为明亮的CD45表达且缺乏不成熟标志物的表达,这可能成为诊断难题,并且难以与缺乏表面CD3表达或异常表达不成熟标志物的成熟T细胞淋巴瘤相鉴别,而这会影响治疗决策和预后。在此,我们总结了3例具有完全成熟免疫表型的儿童T-ALL病例的临床、病理和遗传学特征。

相似文献

1
Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging Diagnosis.具有完全成熟免疫表型的小儿T淋巴细胞白血病:快速且具有挑战性的诊断
J Pediatr Hematol Oncol. 2025 Jan 1;47(1):e58-e61. doi: 10.1097/MPH.0000000000002967. Epub 2024 Dec 31.
2
CD3 negative T-ALL - A case study of three cases and review of the literature.CD3阴性T细胞急性淋巴细胞白血病——三例病例研究及文献综述
Indian J Cancer. 2025 Jan 1;62(1):156-161. doi: 10.4103/ijc.ijc_505_21. Epub 2025 May 16.
3
An Anti-CD7 Antibody-Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL).一种针对 T 淋巴细胞白血病(T-ALL)的靶向 CD7 的抗体药物偶联物,具有强大的抗肿瘤活性。
Biomolecules. 2024 Jan 15;14(1):106. doi: 10.3390/biom14010106.
4
Decoding the diagnostic biomarkers of mitochondrial dysfunction related gene variants in pediatric T cell acute lymphoblastic leukemia.解码小儿T细胞急性淋巴细胞白血病中线粒体功能障碍相关基因变异的诊断生物标志物
Sci Rep. 2025 Jul 1;15(1):21144. doi: 10.1038/s41598-025-08893-4.
5
Immunophenotype of CAR T cells and apheresis products predicts response in CD22 CAR T cell trial for B cell acute lymphoblastic leukemia.嵌合抗原受体(CAR)T细胞和单采产物的免疫表型可预测B细胞急性淋巴细胞白血病CD22 CAR T细胞试验中的反应。
Mol Ther. 2025 Mar 13. doi: 10.1016/j.ymthe.2025.03.019.
6
Altered Levels of and in Exosomes of Patients Recently Diagnosed With Acute Lymphoblastic Leukemia.近期诊断为急性淋巴细胞白血病患者外泌体中[具体物质]水平的改变
In Vivo. 2025 Jul-Aug;39(4):1941-1964. doi: 10.21873/invivo.13993.
7
Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis.儿童急性淋巴细胞白血病微小残留病评估:一项经济学分析。
Ont Health Technol Assess Ser. 2016 Mar 8;16(8):1-83. eCollection 2016.
8
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.嵌合抗原受体T细胞(CAR-T)疗法时代小儿急性淋巴细胞白血病的移植后复发。西班牙血液移植与细胞治疗协作组(GETH-TC)儿科委员会的多中心分析
Cytotherapy. 2025 Apr;27(4):438-445. doi: 10.1016/j.jcyt.2024.11.016. Epub 2024 Dec 2.
9
Advances in Pediatric Lymphoblastic Lymphoma: Demographic, Clinical Characteristics, Treatment and Long-Term Outcome: A Single-Center Retrospective Analysis.儿童淋巴细胞淋巴瘤的进展:人口统计学、临床特征、治疗及长期预后:一项单中心回顾性分析
Turk Arch Pediatr. 2025 Jul 1;60(4):379-383. doi: 10.5152/TurkArchPediatr.2025.25017.
10
CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.CD2和CD7是T系急性白血病敏感的流式细胞术筛选标志物:465例急性白血病病例的研究
Hum Pathol. 2021 Aug;114:66-73. doi: 10.1016/j.humpath.2021.05.007. Epub 2021 May 18.

引用本文的文献

1
The Flow Cytometric Evaluation of B- and T-Lymphoblastic Leukemia/Lymphoma.B 淋巴细胞母细胞性白血病/淋巴瘤和 T 淋巴细胞母细胞性白血病/淋巴瘤的流式细胞术评估
Cancers (Basel). 2025 Mar 26;17(7):1111. doi: 10.3390/cancers17071111.